Atlas Trials

To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer

Clinical trial NCT06315270 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06315270
Sponsor
The First Hospital of Jilin University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Epithelial Ovarian CancerStage III Ovarian CancerStage IV Ovarian Cancer
Start date
2024-03-20
Primary completion
2029-03-20
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.